A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

Gain expert insights into best practices and emerging strategies in CAR T-cell therapy for patients with leukemia lymphoma and myeloma with this dynamic online educational program based on a live Webinar. Download slides with all the key data watch the on-demand Webcast and join the conversation around an expert-authored commentary.

Share

Program Content

Activities

CAR T Advances
Recent Advances in CAR T-Cell Therapy for Hematologic Malignancies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Activities

CAR T: ALL
An Overview of CAR T-Cell Therapy and Review of Clinical Outcomes of CAR T-Cell Therapies for ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

CAR T: Lymphomas
CAR T-Cell Therapy Against NHL and CLL: Current and Emerging Clinical Trial Evidence
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

CAR T: Myeloma
Emerging CAR T-Cell Therapies in Myeloma and Management of Key Toxicities
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

<i>EP</i>: CAR T
ExpressPoints: CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2020

Expires: December 07, 2021

No activities added yet

Faculty

cover img faculity

Renier J. Brentjens, MD, PhD

Associate Professor
Department of Medicine
Weill Medical College of Cornell University
Associate Professor
Department of Pharmacology
Weill Cornell Graduate School of Medical Sciences
Associate Attending
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Frederick L. Locke, MD

Co-Leader, Moffitt Immuno-Oncology Program
Vice Chair and Associate Member
Department of Blood and Marrow Transplant and Cellular Immunotherapy
Research Director
Medical Director

Immune Cell Therapy Program
Blood and Marrow Transplant and Cellular Immunotherapy
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Michael Wang, MD

Associate Professor
Department of Lymphoma and Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb